Agencies rock for a good cause at Pharmapalooza

Share this article:
Agencies rock for a good cause at Pharmapalooza
Agencies rock for a good cause at Pharmapalooza

Corbett Accel Healthcare Group can add music to its list of creative achievements after its Chicago office triumphed in last night's Pharmapalooza “battle of the bands” contest at B.B. King's Blues Club & Grill in New York City.

Heavy Medical — comprising Jeff Holtorf (drums), Terry Barich (harmonica, vocals), Brian Catral (keyboards, vocals), Jack Cunningham (bass, vocals), Joe Mason (theremin, vocals), Matt Pearl (guitar, vocals) Nicole Stachura (percussion, vocals) and Kelly Christiansen (percussion, vocals) — rocked a sell-out crowd of 750 vociferous industry colleagues and supporters.

In second place was Late Night Car Service (a.k.a. Sudler & Hennessey) which got the vote from MM&M's unofficial panel in attendance. But the real winners of the charity event, which was conceived and organized by New York-based Cline Davis & Mann, was the Children's Hospital at Montefiore, for whom more than $110,000 was raised.

Other contestants were May Cause Nausea (Ogilvy Healthworld), Grand pRx (GSW Worldwide), Pharmatopia (Corbett Accel New York), Mr. Tiny's Revenge (Grey Healthcare Group), SIDEFX (Regan Campbell Ward • McCann), BANDRx (AgencyRx) and Black Box Warning (Harrison & Star). CDM had set the tone with an impressive opening set from its 21-member ensemble, Uncle Funkus.

 

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...